---
trial_id: 642
discovery_date: 2022-04-15 12:12:54.115783
date: 2022-04-15 12:12:54.115783
title: "A 52-week, Two Arm, Randomized, Open-label, Multicenter Study Assessing the Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens for Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration"
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct04679935'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
